Arkolith/Insider Trading/MRKR/Form 4

Eansor Norman David

DirectorMarker Therapeutics, Inc. (MRKR) · full profile →Form 4 · filed Jun 8, 2023
Net Buying
Open-Market Buys
$250K
Open-Market Sells
$0
Net Open-Market Flow
$250K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 25, 2021Gift(G)7K—$07K
Mar 25, 2021Gift(G)14K—$02K
Mar 25, 2021Gift(G)7K—$07K
Mar 16, 2021Buy(P)14K$17.50$250K17K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 6, 2023Grant(A)8K—$08K

Transaction Codes

G
Gift
P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-035617) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Marker Therapeutics, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp